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Purpose: Gloriosa superba Linn (liliaceae) has been used to induce labor in the traditional Indian 
system of medicine. The objective of the study was to evaluate the activity of the aqueous extract of 
Gloriosa superba (AL) root on the female reproductive system of rat.  
Methods: The aqueous extract of Gloriosa superba was prepared by simple maceration. Phytochemical 
analysis as well as toxicity (in mice) and antifertility studies, uterotrophic assay, duciduoma model, 
uterotonic assessment in-vitro and in-vivo of aqueous extract was carried out in rats. Oxytocin was used 
as the uterotonic reference standard. The effect of the extract on cardiovascular parameters was also 
evaluated.  
Results: Phytochemical analysis shows presence of flavonoids, tannins, alkaloids, and glycosides in the 
aqueous extract of Gloriosa superba. The extract yield was 6 % and was found to be was safe at a dose 
as high as 550 mg/kg body weight. Antifertility study showed early abortificient activity. No increase in 
uterus and ducidual weight was observed. Both the reference (oxytocin) and the extract produced dose-
dependent contractions but the extract had no effect on heart parameters and blood pressure.  
Conclusion: The aqueous extract of Gloriosa superba showed oxytocic activity and early abortifacient 
activity which may be due to the presence of alkaloids such as colchicine. This provides justification for 
its use in traditional medicine. 
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INTRODUCTION 
 
Most of the plants claimed to be oxytocics are 
used to induce and maintain labour, aid the 
removal of retained placenta, regulate post-
partum bleeding and as abortifacient. The 
plant extracts increase the spontaneous 
activity of the uterus causing increase in 
contractions [1]. Some animal products have 
also been used to induce labour and removal 
of retained placenta, e.g., Hippopotamus 
amphibious (skin and meat) and Panthera leo 
(fats and faeces) which are boiled and the 
cooled decoction administered orally. 
Medicinal plants used to speed the birth 
process are usually administered towards the 
end of the gestation period or at the onset of 
labour labor pains. Plants that produce 
uterine contractions have a similar action to 
that of oxytocin which stimulates the uterus, 
causing strong contractions, and thus 
producing labour [2]. Traditional birth 
attendants, mothers-in-law, mothers and the 
expectant mother mostly prescribe these 
herbal remedies to induce labour. Some of 
these medicinal plants are also fed to cows 
and goats in labour. 
 
Gloriosa superba L., (Langli), is widely 
distributed in the tropical jungles of Africa and 
in many parts of tropical Asia, including India, 
Burma, Malaysia and Srilanka[10]. In India, it 
is mainly found in Nasik, Ratnagiri and 
Savanthwadi in Maharashtra state; Uttar 
Kannada, Hassan, Chikmangalur, Coorg and 
Mysore in Karnataka state; Cannanore, 
Palakkad and Trivandrum in Kerala state; as 
well as in Tamil Nadu and Goa. It is an erect, 
perennial, climbing herb. Tribesmen of 
Patalkot apply the rhizome extract over the 
navel and vagina to induce labour and 
facilitate normal delivery. According to them, 
250 to 500 mg of the extract may lead to 
abortion if given to a lady with a pregnancy of 
1 - 2 months [3]. It is also used for the 
treatment of ulcers, leprosy, piles, 
inflammations [4], intestinal worm 
infestations, thirst, bruises, skin problems and 
snakebite [5,6]. Although some pharma-
cological studies have been carried out on 
this plant [7], to the best of our knowledge, 
there is no report on its effect on the 
reproductive system. In view of its folkloric 
use, the first objective of this study was to 
evaluate the effect of the aqueous extract of 
the root of Gloriosa superba L. on the 
reproductive system of rat. Since 
hypertension is one of the most common 
medical problems encountered during 
pregnancy, causing complications in 2 – 3 % 
of pregnancies [8], the second objective was 







Histamine and estrogen benzoate (1mg/ml, 
Himedia Labs, India); hydroxyprogesterone 
caproate (German Remidies, India); oxytocin 
injection (Ranbaxy Laboratories Limited, 
India), adrenaline bitartarate and atropine 
sulphate injection (T. Walker’s Pharma-
ceuticals Pvt. Ltd, Pune, India); and De-
Jalons solution (comprising 9.0 g of NaCl, 4.2 
ml of 10 % KCl, 0.27 ml of 1M CaCl2, 0.5 g of 
glucose and 0.5 g of NaHCO3 in 1 L of 
distilled water) were the main materials used. 
 
Collection and identification of plant 
material 
 
The roots of Gloriosa superba L. were 
collected from a local market in Pune City, 
Maharashtra, India and authenticated by Dr A 
M Mujumdar a taxonomist and Head, Plant 
Sciences Division, Agharkar Research 
Institute, Pune, Maharashtra, India. The plant 
specimen was deposited in the herbarium of 
Agharkar Research Institute, Pune, India 




All the animal experiments were performed 
on in-bred adult female Wistar rats (weighing 
250 - 300g) . They were maintained at a 
temperature of 25 ± 1°C and relative humidity 
of 45 - 55 % under 12h light/12h dark cycle. 
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The animals had free access to food pellets 
(Chakan Oil Mills, Pune, India) and water. 
The experimental protocol was approved by 
the Institutional Animal Ethics Committee 
(IAEC) of Poona College of Pharmacy, Pune, 
India, (approval ref no. CPCSEA/32/2008) 
and followed the guidelines of India’s 
Committee for the Purpose of Control and 
Supervision of Experiments on Animals 
(CPCSEA) [22]. 
 
Preparation of extract 
 
Gloriosa superba root powder (100 g) was 
defatted with 150 ml of petroleum ether (b.p. 
40 - 60 ºC). Cold maceration by addition of 
distilled water (150 ml) to dried, defatted 
Gloriosa superba root powder was carried out 
for 24 h in a flask using a mechanical shaker. 
The supernatant was removed, the marc 
dried and again macerated with 150 ml of 
distilled water for 24 h. The extract was 
filtered through Whatman filter paper no. 44 
and dried in a tray dryer at 30 ºC. The yield 
was 6 %. The extract was reconstituted in 
distilled water prior to pharmacological tests. 
 
Preliminary phytochemical tests 
 
The extract was analyzed for phytochemicals 
including steroids using Salkowski test [9], 
flavonoids and tannins using ferric chloride 
test [10], alkaloids by Mayer’s test [11], and 
proteins and glycosides by Biuret and Legal 
tests, respectively [12,13]. 
 
Acute oral toxicity study 
 
For acute oral toxicity and LD50 
determination, OECD (Organization for 
Economic Cooperation and Development) 
guideline AOT-425 was followed [14]. Healthy 
adult Swiss mice of either sex weighing 
between 20 - 25 g were used for acute oral 
toxicity study. Food, but not water, was 
withheld for 4 h before the drug was 
administered orally. The test drug was given 
in doses of 5000, 1750, 550 mg/kg p.o.; the 
number of mice per dose was three. The 
mice were observed for 2 h for behavioural, 
neurological and autonomic profiles and for 
any lethality or death over the next 48 h.  
 
Assessment of antifertility activity of 
extract 
 
Adult female Wistar rats were kept overnight 
with male rats of proven fertility (in the ratio of 
2 females to 1 male) and the vaginal smear 
of the female rats was examined for 
spermatozoa in the morning. The day on 
which the spermatozoa were observed in the 
smear was considered as day zero of 
pregnancy (Day 0) and such female rats were 
divided into four groups of 5 rats each. 
Group-I (Control) received the vehicle 
(distilled water), while the other groups 
received extract as follows: Group-II (50 
mg/kg), Group-III (100 mg/kg), and Group-IV 
(200 mg/kg). The rats received these 
treatments daily for 7 days. On day 10, all the 
animals were laprotomized under light ether 
anesthesia and the number of implantation 
sites in both horns of the uteri was recorded. 
Pregnancy parameters such as length of 
pregnancy (days), pregnancy index (i.e., no. 
of pups delivered/no. of implants, expressed 
as a percentage), no. of pups on day 7 and 
teratogenicity were recorded [15]. 
 
Determination of estrogenic activity of 
extract 
 
Immature female rats (50 – 80 g) were 
bilaterally ovariectomized under light ether 
anesthesia [16]. The animals were classified 
into different groups (6 each). Group-I 
(control) was control while groups II - IV 
received the extract - 50, 100 and 200 mg/kg, 
respectively; Group-V received 0.1 mg 
estradiol benzoate in olive oil 
(subcutaneously) biweekly. The treatment 
period was 28 days. On day 29, the animals 
were sacrificed and dissected, their uteri 
removed and freed from surrounding tissues, 
blotted on filter paper and then weighed 
quickly on an electronic balance. 
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Determination of progestogenic activity 
 
The deciduoma model was used for this 
experiment [17]. Adult female Wistar rats 
weighing 200 to 250 g were ovariectomized. 
The animals were classified, according to the 
extract (unless otherwise specified) dose 
given, as follows: Group-I (Control, vehicle, 
i.e., distilled water), Group-II (hydroxypro-
gesterone caproate (reference, 0.04 
mg/animal, s.c.), Group-III (AL-50 mg/kg), 
Group-IV (AL-100 mg/kg), Group-V (AL-200 
mg/kg). One week later, all the animals were 
treated with 0.5 µg estradiol/animal once 
daily s.c. for 4 days, followed by 
progesterone (Group-II) or extract (Groups-III 
to V in doses of 50, 100 and 200 mg/kg, 
respectively) and vehicle (control group) for 9 
days. The animals were anaesthetized, the 
uterus of each rat exposed on day 5 of the 
preceding treatment, and then 1 mg 
histamine dihydrochloride injected into the 
lumen of the left horn. The animals were 
sacrificed thereafter and the left uterine horn 
from each animal removed and weighed. The 
degree of deciduoma formation was 
evaluated as percent increase in the weight 
of the histamine-injected uterine horn, 
compared with the control horn.. 
 
In-vivo assay of uterotonic activity of 
extract 
 
Microballoon technique was used for this 
assay. Adult female Wistar rats weighing 250 
to 300 g were divided into two groups each 
containing six animals, and primed with 100 
µg of estradiol benzoate s.c. 24 h prior to the 
experiment. The rats showing estrous phase 
were selected for the experiment. Each 
animal was anaesthetized with urethane 
(1.25 g/kg) and the jugular vein cannulated 
for drug administration. A small incision was 
made on the lower abdominal skin and the 
uterus exposed. Another small incision was 
made near the midrostral end of the left 
uterine horn. A saline-filled catheter with a 
microlatex balloon on its end (approx 2 cm 
diameter) was inserted into the lumen of the 
uterine horn and secured to it by stitching 
[18]. The catheter was connected to a 
pressure transducer and normal uterine 
contractions were recorded using an 8-
channel recorder (Power Lab, model 8/30, 
AD Instruments, Australia). The extract (0.2, 
0.4 or 0.8 mg/kg, i.v) and oxytocin (0.2, 0.4 or 
0.8 µg/kg, i.v) were administered to two 
different groups of female rats. The dose 
responses of oxytocin (reference) and the 
extract were recorded until a ceiling effect 
was observed.  
 
In-vitro assay of uterotonic activity of 
extract 
 
Adult female Wistar rats weighing 120 to 200 
g were primed with 100 µg of estradiol 
benzoate s.c. 24 h prior to the experiment. 
The rats showing estrous phase were 
selected for the experiment, sacrificed by 
cervical dislocation and the uterus was 
removed. One horn of the uterus was 
mounted on an organ bath containing De-
Jelon’s solution and allowed to stabilize for 
45 min during which the tissue was washed 
at least 4 times with fresh De-Jelon’s 
solution. Dose response was recorded for 
oxytocin (0.05 – 0.8 µg) and the extract (0.1 - 
6.4mg) until a ceiling (peak) effect was 
observed. The response of the extract was 
compared with that of oxytocin (reference) 
response [19]. 
 
Effect of extract on blood pressure (BP) 
and electrocardiogram (ECG) of female rat  
 
Adult female Wistar rats weighing 200 to 250 
g were anesthetized with urethane (1.25 
g/kg) and the jugular vein cannulated for 
administration of the extract. The carotid 
artery was cannulated for the recording of 
blood pressure (BP) while electrocardiogram 
(ECG) electrodes were attached to the right 
and left forelimb and right hindlimb for 
recording of ECG.  ECG, BP and heart rate 
were recorded using an 8-channel recorder 
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Control 6 6 54 55 0 0 21.5 ± 0.2 101.9 ± 0.0 
50  5 5 47 33*** 0 1 21.4 ± 0.2 90 ± 0.0* 
100  5 5 51 42* 0 0 21.6 ± 0.2 72.7 ± 0.0*** 
AL(200) 6 3 33*** 24*** 50 0 21.7 ± 0.3 82.2 ± 0.0*** 
 
p*< 0.01, **p < 0.001, *** p < 0.0001 compared with control group. 
 
Statistical analysis  
 
The arithmetic means of the data were 
calculated for each experiment. The results 
were subjected to statistical analysis using 
one-way analysis of variance followed by 
Dunnett’s test. The level of significance used 
was p < 0.05. The statistical software used 





Preliminary phytochemical assessment 
showed that the aqueous extract of roots of 
Gloriosa superba contains flavonoids, 
tannins, alkaloids and glycosides, while acute 
toxicity studies indicate that the extract was 
safe up to a dose level of 550 mg/kg of body 
weight. 
 
Antifertility activity of extract 
 
The antifertility data for the extract are shown 
in Table 1. The reduction in pregnancies, 
based on the number of rats showing 
implants on day 10 of laprotomy was 0 % for 
control and all extract doses except for 200 
mg/kg which was 50 % (p < 0.05). The 
extract reduced the number of pups born 
when compared to the number of implants 
present in the uterus on day 10 of laprotomy. 
The reduction was significant for all three 
doses of the extract. However, none of the 
test animals from days 1 - 22 of pregnancy 
irrespective of the treatment received. 
Gestation period was approximately 21 days 
for all the animal groups and all the pups 
born survived up to the 7
th
 post-natal day, the 
number being, 8 or 9 per group. Pregnancy 
index (PI) of the control group was 101.9 % 
while for extract groups, it was 90 (50 mg/kg, 
p < 0.01), 72.7 (100 mg/kg, (p < 0.0001). and 
82.2 % (200 mg/kg, p < 0.0001), respectively. 
 
Effect of G. superba (AL) extract on uterus 
weight  
 
Table 2 shows the effect of the extract on the 
uterus weight of immature female rats. The 
administration of estradiol benzoate provoked 
a significant increase (p < 0.001) in uterus 
weight compared with control while extract 
administration (all  doses)  did  not   increase 
uterus weight significantly. Similarly, while 
administration of hydroxyprogesterone capro- 
 
Table 2: Effect of AL extract on uterus weight 












AL (50 mg/kg) 59.8±5.2 132.0 ± 12.4 
AL(100 mg/kg) 70.0 ± 4.6 187.0 ± 41.1 
AL(200 mg/kg)  79.6 ± 5.8 183.5 ± 25.5 
Progesterone  
(1 mg/kg,) 
- 340.0 ± 24.1* 
 
 *p < 0.01, ** p < 0.001 compared with control group. 
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ate significantly increased (p < 0.01) the 
weight of uterine horn, the extract, at all 
doses, did not; although the 50 mg/kg 
appeared to have reduced the weight of the 
uterine horn, this was not statistically 
significant.  
 
Effect of G. superba extract (AL) on rat 
uterine contractility  
 
Fig 1 shows the spasmogenic activity (i.e., 
contraction) of the rat uterus of the extract in 
estrogen-primed non-pregnant uterus in-vivo 
while Fig 2 indicates the same parameter in 
vitro. 
 
The extract treatments produced increase in 
uterine contractility both in vivo and in vitro 
but height of contractions produced by the 
extract was slightly less than that produced.  
 

























Figure 1:  In-vivo effect of G. superba extract (AL) and 
oxytocin (reference) on rat uterine contractions  
 


























Figure 2: In-vitro effect of G. superba extract (AL) and 
oxytocin (reference) on rat uterine contractions 
Effect of G. superba (AL) extract on rat 
cardiovascular parameters 
 
Table 3 indicates that the extract had no 
significant effect on rat blood pressure and 
heart rate when compared with the control 
group. 
 
Table 3: Effect of G. superba extract (AL) on 
cardiovascular parameters of rat (mean ± SEM) 
 


































The persistent use of plants by pregnant 
women and traditional birth attendants for the 
induction of labor suggests that some herbs 
might be potent uterine stimulants. Therefore, 
studies of such herbs could provide a helpful 
guide to the discovery of new oxytocics. 
Gloriosa superba is used for labour induction 
by traditional birth attendants in India.  
 
Phytochemical analysis of the extract showed 
presence of flavonoids, tannins, alkaloids, 
and glycosides in the aqueous extract of 
Gloriosa superba. The extract (AL) was safe 
up to a dose of 550 mg/kg which is approx. 
10 times higher than the minimum dose at 
which the extract effectively reduced the 
number of pups produced. While the extract 
had significant anti-implantation and early 
abortifacient activities, gestation period and 
pregnancy index were not altered, the extract 
did not show any apparent teratogenicity as 
the pups born seemed normal and no death 
occurred during the 7-day observation period.  
 
It is well known that for implantation to take 
place, the exact equilibrium of estrogen and 
progesterone must obtain, and hence any 
disturbance in the level of these hormones 
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may cause abortion or infertility. In order to 
determine the mechanism of abortifacient 
activity of the extract, two hormones, 
progesterone and estrogen, which have the 
capacity for termination/reduction of 
pregnancy were used in the study to 
ascertain whether the extract exhibits 
estrogenic and progestogenic activities. The 
failure of the extract to increase the uterine 
weight suggests absence of estrogenic 
activity. Similarly, progestogenic activity was 
not manifest as the extract did not increase 
decidual (uterine horn) weight. 
The uterine contractility of the extract may be 
due to its oxytocic effects. The effect was fast 
in onset and could be totally eliminated by 
washing with extract-free Dejalon solution, 
thus suggesting the presence of low 
molecular weight active compound(s) in the 
extract, which may have penetrated rapidly to 
the site of action. 
However, the extract demonstrated 
spasmogenic activity, which was not as 
strong as that of oxytocin, Thus, its anti-
implantation and early abortifacient activity 
may be due to its oxytocic property. The 
ability to cause uterine contractility raises the 
possibility of its being developed as a 
medicine for induction of labour. Since many 
pregnancies are associated with gestational 
hypertension, it is worth noting that the 
extract had no effect on blood pressure and 




The tests carried out on G. superba extract 
indicate that its mechanism of action was 
neither estrogenic nor progesterone like.  
However, its early abortifacient activity 
appears to suggest that its activity is oxytocic. 
Nonetheless, further studies are required to 
determine which phytochemical constituents 
are responsible for the plant’s abortifacient 
and oxytocic activities. The absence of any 
effects on the cardiovascular parameters 
enhances the plant extract’s safety profile in 
pregnancy. Overall, the study lends some 
credence to the folkloric use of Gloriosa 
superba Linn. (Langli) in labour induction. 
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